At a glance
The November 2, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on CMS reimbursement, the College of American Pathologists (CAP) Microbiology Committee perspective, and the FDA.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)
CMS Reimbursement Update: Sarah Harding, Centers for Medicare & Medicaid Services (CMS)
College of American Pathologists (CAP) Microbiology Committee Perspective: Caution Must Be Used in Interpreting the Cycle Threshold (Ct) Value: Daniel Rhoads, Cleveland Clinic
FDA Update: Sara Brenner and Toby Lowe, U.S. Food and Drug Administration (FDA)
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.